Topline data from the phase 3 E-BEOND and C-BEOND trials show a significant reduction in monthly migraine days at 24 weeks, demonstrating efficacy across the full migraine spectrum.

Experts discuss the bidirectional relationship between financial toxicity and cardiovascular disease outcomes in the US ...

BC, presented ways in which artificial intelligence (AI) can be part of the solution to widespread burnout among NPs. Dr ...

Chronic pain and cancer pain management require a multimodal approach that addresses physical, emotional, and spiritual ...

Illustration courtesy of Anne Pavlik A clinical approach applying 3 distinct syndromes helps clinicians differentiate benign from catastrophic causes of vertigo, such as stroke. This complexity, and ...

At AANP 2026, clinicians share how NPs are on the front lines of asthma management, necessitating a full understanding of the latest GINA guidelines. The GINA guidelines no longer recommend using a ...

While Study 1 demonstrated a statistically significant reduction in knee OA pain with ReNu, Study 2 failed to meet its primary efficacy endpoint despite a numerical trend favoring the active treatment ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes. A high percentage of primary care patients with an active continuous glucose ...

Researchers evaluated the real-world efficacy of statewide doxycycline post-exposure prophylaxis against common sexually transmitted infections.

Online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors frequently do not require clinician interaction, according to a research letter published online July 6 in the Journal ...

Recompensation in alcohol-related hepatitis (AH) is relatively common, especially with alcohol abstinence, according to study findings published in Clinical Gastroenterology and H ...

Researchers evaluated the efficacy of cannabinoid-based therapies for managing agitation and neuropsychiatric symptoms in Alzheimer disease.